SCHEMBL2910641

SCHEMBL2910641

Cc1c(Cl)c(Cl)nc(Cl)c1C#N

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.59
HTT P42858 6/20 0.48
KMT2A Q03164 4/20 0.48
MEN1 O00255 3/20 0.48
GLA P06280 2/20 0.48
TSHR P16473 1/20 0.48
KDM4E B2RXH2 4/20 0.44
L3MBTL1 Q9Y468 2/20 0.43
GAA P10253 5/20 0.40
TP53 P04637 2/20 0.40
HPGD P15428 2/20 0.40
LMNA P02545 2/20 0.40
SMN1; SMN2 Q16637 3/20 0.39
MAPT P10636 2/20 0.39
MAPK1 P28482 2/20 0.39
CYP3A4 P08684 2/20 0.39
CACNA1B Q00975 1/20 0.38
APBA1 Q02410 1/20 0.38
APOBEC3G Q9HC16 1/20 0.38
THRB P10828 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13329219 0.88 ALDH1A1 (0.72) ALDH1A1HTTKMT2AMEN1GLA
SCHEMBL29799018 0.84 KMT2A (0.61) ALDH1A1HTTKMT2AMEN1GLA
SCHEMBL8471830 0.84 KMT2A (0.61) ALDH1A1HTTKMT2AMEN1GLA
SCHEMBL11822208 0.84 ALDH1A1 (0.61) ALDH1A1HTTKMT2AMEN1GLA
SCHEMBL31184166 0.84 ALDH1A1 (0.61) ALDH1A1HTTKMT2AMEN1GLA
SCHEMBL11100290 0.81 KMT2A (0.44) ALDH1A1HTTKMT2AMEN1GLA
SCHEMBL19734857 0.78 ALDH1A1 (0.55) ALDH1A1HTTKMT2AMEN1GLA
SCHEMBL2561930 0.78 KMT2A (0.50) ALDH1A1HTTKMT2AMEN1GLA
SCHEMBL2911376 0.78 KMT2A (0.64) ALDH1A1HTTKMT2AMEN1GLA
SCHEMBL2905211 0.78 ALDH1A1 (0.50) ALDH1A1HTTKMT2AMEN1GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113929622-B Synthesis method of 2,5, 6-trichloro-cyanogen 山西永津集团有限公司 2023-11-10 CN claimed
CN-113929622-A Synthetic method of 2,5, 6-trichloro-cyanic acid 山西永津集团有限公司 2022-01-14 CN claimed
CN-113929622-B Synthesis method of 2,5, 6-trichloro-cyanogen 山西永津集团有限公司 2023-11-10 CN disclosed
CN-113929622-B Synthesis method of 2,5, 6-trichloro-cyanogen 山西永津集团有限公司 2023-11-10 CN disclosed
CN-113929622-A Synthetic method of 2,5, 6-trichloro-cyanic acid 山西永津集团有限公司 2022-01-14 CN disclosed
CN-113929622-A Synthetic method of 2,5, 6-trichloro-cyanic acid 山西永津集团有限公司 2022-01-14 CN disclosed
US-10342782-B2 Positive allosteric modulators of the muscarinic acetylcholine receptor M4 VANDERBILT UNIVERSITY (US) 2019-07-09 US disclosed
US-10342782-B2 Positive allosteric modulators of the muscarinic acetylcholine receptor M4 VANDERBILT UNIVERSITY (US) 2019-07-09 US disclosed
US-20180028501-A1 POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 VANDERBILT UNIVERSITY 2018-02-01 US disclosed
US-20180028501-A1 POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 VANDERBILT UNIVERSITY 2018-02-01 US disclosed
US-20180028501-A1 POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 VANDERBILT UNIVERSITY 2018-02-01 US disclosed
US-8071776-B2 Thienopyridines as allosteric potentiators of the M4 muscarinic receptor ELI LILLY AND COMPANY (US) 2011-12-06 US disclosed
US-8071776-B2 Thienopyridines as allosteric potentiators of the M4 muscarinic receptor ELI LILLY AND COMPANY (US) 2011-12-06 US disclosed
US-8071776-B2 Thienopyridines as allosteric potentiators of the M4 muscarinic receptor ELI LILLY AND COMPANY (US) 2011-12-06 US disclosed
EP-1807434-B1 THIENOPYRIDINES AS ALLOSTERIC POTENTIATORS OF THE M4 MUSCARINIC RECEPTOR LILLY CO ELI (US) 2010-08-25 EP disclosed
US-20090105244-A1 THIENOPYRIDINES AS ALLOSTERIC POTENTIATORS OF THE M4 MUSCARINIC RECEPTOR ELI LILLY AND COMPANY (US) 2009-04-23 US disclosed
US-20090105244-A1 THIENOPYRIDINES AS ALLOSTERIC POTENTIATORS OF THE M4 MUSCARINIC RECEPTOR ELI LILLY AND COMPANY (US) 2009-04-23 US disclosed
US-20090105244-A1 THIENOPYRIDINES AS ALLOSTERIC POTENTIATORS OF THE M4 MUSCARINIC RECEPTOR ELI LILLY AND COMPANY (US) 2009-04-23 US disclosed
EP-1807434-A1 THIENOPYRIDINES AS ALLOSTERIC POTENTIATORS OF THE M4 MUSCARINIC RECEPTOR ELI LILLY AND COMPANY (US) 2007-07-18 EP disclosed
WO-2006047124-A1 THIENOPYRIDINES AS ALLOSTERIC POTENTIATORS OF THE M4 MUSCARINIC RECEPTOR ELI LILLY AND COMPANY (US) 2006-05-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090105244-A1 THIENOPYRIDINES AS ALLOSTERIC POTENTIATORS OF THE M4 MUSCARINIC RECEPTOR CHRM2, CHRM4, CHRM1 ALDH1A1 2594/4885HTT 2251/4885KMT2A 3096/4885
US-10342782-B2 Positive allosteric modulators of the muscarinic acetylcholine receptor M4 CHRM4, CHRM2, CHRM1 ALDH1A1 3342/4885HTT 1807/4885KMT2A 932/4885
US-20180028501-A1 POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 CHRM4, CHRM2, CHRM1 ALDH1A1 3342/4885HTT 1807/4885KMT2A 932/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.